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2Abstract28
Introduction. Brown adipose tissue (BAT) is a thermogenic organ with substantial metabolic capacity29
and has important roles in the maintenance of body weight and metabolism. Regulation of BAT is30
primarily mediated through the ß-adrenoceptor (ß-AR) pathway. The in vivo endocrine regulation of31
this pathway in humans is unkown. The objective of our study was to assess the in vivo BAT32
temperature responses to acute glucocorticoid administration.33
Methods. We studied 8 healthy male volunteers, not pre-selected for BAT presence or activity and34
without prior BAT cold-activation, on two occasions, following an infusion with hydrocortisone (0.235
mg.kg-1.min-1 for 14 hours) and saline, respectively. Infusions were given in a randomized double-blind36
order. They underwent assessment of supraclavicular BAT temperature using infrared thermography37
following a mixed meal, and during ß-AR stimulation with isoprenaline (25 ng.kg fat-free mass-1.min-138
for 60 min) in the fasting state.39
Results. During hydrocortisone infusion, BAT temperature increased both under fasting basal40
conditions and during ß-AR stimulation. We observed a BAT temperature threshold, which was not41
exceeded despite maximal ß-AR activation. We conclude that BAT thermogenesis is present in humans42
under near-normal conditions. Glucocorticoids modulate BAT function, representing important43
physiological endocrine regulation of body temperature at times of acute stress.44
45
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31. Introduction49
There is increasing evidence that brown adipose tissue (BAT) has important physiological roles beyond50
thermoregulation in newborn infants and rodents [1]. Adult humans have significant amounts of BAT51
[2] and, as a highly metabolic tissue with the capacity to oxidize both glucose and lipid, attention has52
turned to its involvement in the pathogenesis of obesity and the metabolic syndrome [3]. BAT is53
characterized by the presence of uncoupling protein (UCP) 1 which uncouples adenosine triphosphate54
(ATP) production by the mitochrondrial respiratory chain, allowing the dissipation of excess chemical55
energy as heat [4]. The principal factors regulating BAT function in healthy adults have yet to be fully56
established due, in part, to the technical limitations of assessing BAT function in vivo. The majority of57
studies in humans have used 18F-fluorodeoxyglucose-positron emission tomography/computed58
tomography (18FDG-PET/CT) as the gold standard to assess BAT activity, but this is constrained by59
exposure to ionising radiation, the scanning protocols involved [5] and its unsuitability for live tracking60
of BAT activation especially after feeding. Systemic β-adrenoceptor (β-AR) activation promotes BAT 61
activity in humans [6], but the role of other endocrine factors remains largerly unknown. The pre-partum62
elevation of cortisol is pivotal in the initiation of nonshivering BAT thermogenesis at birth [7], and63
glucocorticoids have recently been proposed as regulators of BAT activity in healthy adult females [8]64
and in individuals pre-selected for the presence of active BAT [9]. BAT has also been considered to65
contribute to dietary-induced thermogenesis [10, 11], although this concept remains controversial [12].66
We, therefore, studied whether BAT is activated by feeding, or by an acute increase in cortisol under67
basal and β-AR stimulated conditions.  68
2. Materials and Methods69
70
2.1 Subjects71
Eight healthy male volunteers participated in this randomized, double-blind, placebo controlled study,72
conducted between January and March 2015. Individuals were recruited using print and electronic73
advertising and none was selected or screened on the basis of presence of any active BAT. All subjects74
underwent a medical evaluation during a screening visit to ensure they were healthy. No subject had75
any significant past medical history, smoked tobacco or took any regular medications that could affect76
the study’s outcome measures.77
2.2 Study approval78
The study was approved by the Edgbaston NRES Committee, UK (REC reference 14/WM/1085). All79
participants provided written informed consent.80
2.3 Study design81
42.3.1. Clinical Research Facility82
All parts of this study were conducted in a temperature controlled room at the National Institute for83
Health Research (NIHR)/Wellcome Trust Clinical Research Facility (CRF) of the University of84
Birmingham at the Queen Elizabeth Hospital Birmingham, UK. Room temperature was held constant85
at 23-26°C and was monitored using an ambient temperature probe.86
2.3.2 Anthropometric measurements87
Measurements were taken during the screening visit. Waist circumference was measured midway88
between the lower margin of the last palpable rib and the top of the iliac crest, and hip circumference89
at the level of the greater trochanters. Total and regional fat masses were measured by dual-energy x-90
ray absorptiometry (DXA). Visceral fat mass was estimated by DXA using a proprietary algorithm91
provided by the manufacturer [13]. Core temperature was measured with a tympanic thermometer.92
2.3.3. Study visits93
Study visits were identical, except for the nature of overnight infusion, and were at least 2 weeks apart94
(Fig. 1A). Subjects were admitted to the CRF in the afternoon, and a cannula for infusion purposes was95
inserted into a right antecubital fossa vein. At 1800 hours, they were served a standardized calorie-96
controlled meal (vegetable lasagne; total energy 2634 kJ; typical nutritional values per 100g of product:97
1.9g fat, 12.2g carbohydrates, 3.3g protein, 1.5g fibre), and then fasted until study completion the next98
day. BAT thermogenesis assessment was performed immediately before and after the meal, which was99
ingested within 20 min and was acompanied by tap water at room temperature. At 1900 hours, a constant100
infusion of either hydrocortisone (HC, 0.2 mg.kg-1.h-1) or normal saline (control study visit) was started101
and given until study completion the following day. Infusions were administered in a double-blind,102
randomized fashion. At 2200 hours, lights were switched off for night rest. In the morning, cannulations103
for blood sampling purposes were performed and, at 0900 hours, the isoprenaline infusion protocol104
commenced. After baseline measurements for 45 min, a one-step infusion of isoprenaline (ISO, 25105
ng.kg fat-free mass-1.min-1) was given for 60 minutes. BAT thermogenic activity was measured at106
baseline and throughout the infusion.107
2.4. BAT thermogenesis assessment108
An infrared thermography (IT) camera (FLIR E60 2.3 Megapixel Infrared Camera; FLIR Systems AB,109
Danderyd, Sweden) was used to acquire images of the anterior neck and upper chest region, which were110
sequentially analyzed and processed by an automated analysis program, as described previously [14].111
Areas of interest for temperature analysis were the supraclavicular region (TSCR) representing BAT, and112
a non-adipose tissue reference point (TREF) on the chest, close to the xiphoid. In addition, during the113
periods of IT, two skin contact temperature sensors (iButton DS1922L, Maxim Integrated, Winnersh,114
UK) recording skin temperature every minute were taped within the supraclavicular fossa (main BAT115
5site) and lateral to the umbilicus (white adipose tissue). For skin contact temperature measurements,116
data were collected every minute, and analysis was performed using 5-minute averages. For meal117
meaurements, the mean of both study days was calculated. Fasting and pre-ISO baseline were defined118
as the average of time points -15 to 0 min. Postprandial and peak post-ISO infusion periods were defined119
as time points 0 to 15 min and 40 to 50 min, respectively. For the duration of the study, participants120
were wearing a hospital gown, with their torso exposed for the duration of all measurements.121
2.5. Analytical methods122
Blood samples were drawn into heparinized syringes, and plasma was prepared rapidly at 4°C and123
immediately frozen at -80°C before analysis. Plasma glucose and NEFA concentrations were measured124
enzymatically using commercially available kits on an ILAB600 or ILAB650 clinical analyser125
(Instrumentation Laboratory UK, Warrington, UK). Insulin and C-peptide were measured by ELISA126
(Invitron, Monmouth, UK) at a reference laboratory (Diabetes Research Unit Cymru, Swansea127
University, UK). Cortisol was measured by a colorimetric assay (R&D Systems, Abingdon, UK).128
2.6 Calculations and statistics129
Indexes of β-cell function and insulin resistance were calculated according to the homeostatic model 130
assessment (HOMA) method, whereby the mean of three consecutive plasma glucose and insulin131
postabsorptive measurements were used. Energy expenditure was calculated based on heart rate, age132
and weight as previously described [15]. Area under the curve (AUC) was calculated using the trapezoid133
rule and is presented as a time-averaged value (tAUC; AUC divided by the relevant time period).134
Comparisons between groups were analyzed using t test or non-parametric tests for data that were not135
normally distributed. A p<0.05 was considered statistically significant. Based on previous studies using136
a similar integrative physiology design [16], the sample size was designed to have 85% power to detect137
a difference of 0.75 standard deviations at the 5% significance level for metabolic parameters. Data138
were analysed using IBM Statistics for Windows v21 and GraphPad Prism for Windows v6.05. All data139
are presented as mean ± SEM, unless otherwise stated.140
3. Results141
3.1 Meal ingestion leads to increased BAT thermogenic activity142
Baseline anthropometric and metabolic characteristics of participants are shown in Table 1 and143
environmetnal temperature data for each individual study day are shown in Supplemental Table 1.144
There was no difference in outside or room temperature between study days. Following the mixed meal,145
postprandial TSCR increased, whereas TREF remained stable (Fig. 1B). All participants responded with146
an increase in BAT thermogenic activity (Fig. 1C), while core temperature did not change (Fig. 1D).147
Skin contact measurements showed a similar postprandial temperature increase of 0.39±0.10°C over148
6supraclavicular BAT (p<0.05 compared to fasting), whereas skin temperature over white adipose tissue149
remained the same.150
3.2 Acute hypercortisolemia induces peripheral insulin resistance and increases basal BAT151
thermogenic activity152
Overnight HC infusion resulted in significantly increased plasma cortisol concentrations (Fig. 2A).153
From a metabolic perspective, basal plasma non-esterified fatty acids (NEFA) were high due to fasting154
(Fig. 2B). HC increased basal NEFA and glucose (Fig. 2C), as well as insulin (basal insulin 30.4±6.0155
pmol/L vs. 55.2±7.4 pmol/L, p=0.025 control compared to hypercortisolemia) and C-peptide156
concentrations (basal C-peptide 0.25±0.03 pmol/mL vs. 0.38±0.04 pmol/mL, p=0.001 control compared157
to hypercortisolemia). In line with this, HOMA indices of peripheral insulin resistance increased158
(HOMA IR index control 0.62±0.11 vs. hypercortisolemia 1.11±0.16, p=0.016) (Table 2).159
Acute hypercortisolemia increased TSCR in the basal state (Fig. 2D). This was accompanied by an160
increase in basal core temperature (Fig. 2E), but we did not observe any effect on blood pressure or161
heart rate (Fig. 2F).162
3.3 Acute β-AR stimulation increases BAT thermogenic activity during control and 163
hypercortisolemia conditions164
From a metabolic perspective, ISO infusion significantly increased systemic NEFA concentrations,165
both under control and hypercortisolemia conditions (Fig. 2B). Despite the augmentation of basal166
systemic lipolysis by HC, the β-AR dependent rise in plasma NEFA was of similar magnitude compared 167
to control conditions (Δ AUC 953±155 vs 979±175 µmol/L; p=0.926 compared to control). Following168
the initial peak, there was a sharp decline in NEFA concentrations despite continuing ISO infusion.169
Control plasma glucose concentrations were unaffected by ISO, while the observed increase in170
concentrations during HC infusion is due to glucocorticoid-induced peripheral tissue insulin resistance171
(Fig. 2C). This is supported by the concomitant changes in insulin, C-peptide and HOMA indexes172
showing a decrease in glucose sensitivity despite a significant increase in insulin and C-peptide173
concentrations during ISO infusion (Table 1). Expectedly, non-selective β-AR stimulation with ISO 174
increased heart rate and systolic blood pressure, responses not significantly affected by HC (Fig. 2F175
and Supplemental Fig. 1). Basal and ISO-induced BAT thermogenic activity measures did not show176
any significant correlation with BMI or measures of adipose tissue distribution (data not shown).177
Adrenergic stimulation resulted in a highly localized increase in temperature within the supraclavicular178
region, representative of BAT thermogenic activity, both under control and hypercortisolemic179
conditions (Fig. 3). All study participants responded to ISO with an increase in BAT temperature180
(Supplemental Fig. 2). Under control conditions, ISO increased TSCR by 0.7°C, plateaued and then181
returned to baseline after the infusion, implying cessation of β-adrenergic-mediated BAT thermogenesis 182
7(Fig. 3A). These responses to ISO were similar during hypercortisolemia (Fig. 3B), whereby peak TSCR183
was slightly higher (Fig. 3C). The ISO-induced TSCR increase was greater than the physiological184
stimulus of diet-induced thermogenesis (Fig. 3D). Skin temperature showed similar results185
(Supplemental Fig. 3). Energy expenditure increased significantly during ISO (Supplemental Fig. 4).186
During hypercortisolemia, ISO-induced energy expenditure was closely correlated with basal TSCR187
during control conditions (Pearson r=0.742, p=0.035) and peak TSCR during HC (r=0.870, p=0.005). In188
response to ISO, peak core temperature was similar between control and hypercortisolemia conditions189
(Supplemental Fig. 5).190
4. Discussion191
Human supraclavicular BAT is characterised by the presence of thermogenically functional UCP1, with192
a respiratory capacity that substantially exceeds that of white fat [17]. Understanding the endocrine193
factors regulating BAT function is an important prerequisite before being able to utilise the metabolic194
capabilities of this tissue. In this study we sought to study BAT in vivo following exposure to a195
combination of physiological stimuli in order to determine the relative importance of diet and edocrine196
mediated effects.197
BAT glucose uptake has been reported to be increased following a single carbohydrate-rich meal [18],198
although overfeeding for 24h did not have any effect [19]. This has led to some controversy regarding199
the contribution of BAT to dietary-induced thermogenesis in humans. We sought to investigate this200
using a single standardized mixed meal, serving as a physiological stimulus. While we did not measure201
whole body energy expenditure, we observed selective temperature changes over the supraclavidular202
region only, immediately after the meal, suggesting direct BAT activation and not a thermic effect of203
food. Interestingly, from a mechanistic perspective, postprandial BAT activation would be204
characterized by both systemic cortisol secretion [20] and sympathetic β-AR stimulation [21], 205
suggesting an acute maximal response following feeding.206
Cortisol promotes important physiological maturation effects around the time of birth, including raised207
UCP1 abundance in adipose tissue [7, 22]. However, in adult rodents, glucocorticoids inhibit BAT [23]208
by interfering with adrenergic signalling [24, 25]. Human data are scarce with one study reporting209
dexamethasone-induced inhibition of UCP1 expression and metabolic rate in human brown adipocytes210
in vitro [26], and another reporting BAT activation following administration of the synthetic211
glucocorticoid prednisolone in vivo [9]. In our study, we chose hydrocortisone to model a physiological212
acute surge of cortisol, as seen during the perinatal period and at times of acute stress. We observed an213
increase of basal TSCR during hypercortisolemia, supporting a physiological role for cortisol in BAT214
activation, as we did not observe any additive effects on blood pressure or heart rate. The duration of215
the infusion was chosen to allow for glucocorticoid-mediated genomic effects to take place [27]. While216
8the achieved plasma cortisol concentrations were in excess of those typical for acute stress [28], it is217
important to note that tissue-responsiveness can be determined by tissue-specific glucocorticoid218
metabolism rather than absolute plasma concentrations [29]. Taken together our data indicate the219
positive relationship between cortisol and BAT temperature as previously indicated from a small study220
on healthy adult females [8].221
ß-AR stimulation induces BAT thermogenesis in humans [6, 30], although findings are inconsistent222
depending on the ß-AR employed [31, 32]. We found a localised increase in supraclavicular temperature223
during ISO infusion both under control and hypercortisolemia conditions. This temperature change was224
temporally limited for the duration of the infusion, suggesting underlying BAT activation. TSCR225
responses for all subjects increased within the first 5 minutes which is in accordance with acute cold226
exposure on BAT [14]. The observed TSCR plateau is suggestive of a limit to BAT thermogenesis in227
vivo. The concomitant sharp decline in NEFA concentrations during the later stages of the infusion is228
consistent with β-AR desensitization due to maximal receptor stimulation [16]. The finding of a slightly 229
higher peak TSCR during hypercortisolemia suggests a minor synergistic effect between cortisol and ß-230
AR stimulation. Interestingly, the two pathways are intrinsically connected as catecholamine synthesis231
is under glucocorticoid control [33].232
Previous studies have shown that active BAT decreases with age and obesity, and its activation varies233
between sexes [14, 34]. We studied BAT activity in healthy males using IT to assess temperature234
changes in the supraclavicular region and a non-adipose tissue reference point. Supraclavicular skin235
temperature increases upon BAT activation [35, 36] and IT has been shown to measure changes in skin236
temperature overlying the main BAT depot in humans [14]. It has been confirmed as a reliable237
alternative for in vivo BAT activity assessment, correlating with 18FDG-PET/CT [9, 37], with the238
additional benefit of enabling real-time tracking of temperature changes. IT-derived BAT temperature239
measurements might be influenced by subcutaneous adipose tissue thickness [38], however, in our study240
participants were lean and we monitored dynamic temperature changes over time, as opposed to a241
single, static measurement. Adrenoceptor-induced vasodilation, both as a result of HC and ISO242
infusions, could increase skin blood flow and interfere with IT measurements. However, compared to243
TSCR, there were clear temporal differences in the change in TREF which showed a later initial increase244
and a sustained increase post-infusion. Overall, we demonstrate a BAT-specific thermogenic and245
vasodilation response to both HC and ISO, clearly differentiated from non-BAT reference areas,246
confirming that the temperature responses we measured are confined to BAT.247
Our findings support previous studies showing β-AR stimulation as a means of activating BAT in 248
humans [6, 30], confirming IT as a sensitive, non-invasive method for the in vivo assessment of BAT249
function in humans under near-normal conditions [9, 14, 37]. This is particularly important when250
9comparing our results with those studies using glucose tracer uptake as an index of BAT activity.251
Similar ISO doses did not show any significant BAT glucose tracer uptake, likely due to competition252
between the tracer and fatty acids from ISO-induced lipolysis combined with increased insulin253
resistance [32]. Given that BAT primarily utilizes fatty acids for heat generation [1], it is possible that254
18FDG-PET/CT underestimates the amount of active BAT in humans. This limitation has led to the255
development of alternative BAT assessment methods, in addition to IT, either using different PET/CT256
tracers [39], or based on magnetic resonance imaging techniques [40]. We demonstrate that temperature257
changes in the supraclavicular area upon β-AR stimulation are indicative of localised BAT activity in a 258
cohort of unselected young individuals, maintained at room temperature. This supports the prospect of259
harnessing BAT activity and the associated increase in energy expenditure as a potential treatment for260
metabolic diseases. We provide further evidence that in humans, in contrast to rodents, acute261
hypercortisolemia does not inhibit BAT function, but results in BAT activation [9]. Despite this, there262
is a threshold of activity that cannot be overcome even during maximal short-term β-AR stimulation. 263
Our study has some limitations by design, including the small size of our sample, although it is standard264
for a healthy volunteer study of this type. The acute infusion of hydrocortisone limits the conclusions265
we can draw in relation to states of chronic glucocorticoid excess that are associated with profound266
metabolic changes, i.e. Cushing’s Syndrome. In addition, the concomitant induction of relative insulin267
resistance during hydrocortisone infusion might have obscured glucocorticoid-specific effects on BAT268
function, especially since there is a complex relationship between insulin-mediated glucose uptake and269
BAT perfusion and activity in vivo [41]. The strenghts of our study are the randomized double-blind270
design of the infusion protocol and that all measurements were carried out within a short period of time,271
reducing the confounding effect of variations seasonal temperature, and thus endogenous BAT activity.272
In addition, by using IT for the assessment of BAT thermogenic activity, we were able to perform live273
tracking of BAT function in response to experimental stimuli.274
In conclusion, glucocorticoids modulate BAT thermogenesis and may represent an important275
physiological mechanism for maintaining human body temperature at times of acute stress. Our study276
suggests that transient stress could act to promote BAT function. This suggests that depending on the277
type and magnitude of stress BAT could be utilised to improve body weight regulation and metabolic278
homeostasis.279
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400
Figure captions401
Figure 1402
Study design and temperature responses to a meal. Each participant underwent the study twice, whereby403
BAT thermogenic activity was studied with infrared thermography before and after a standardized meal,404
followed by either a 14 h overnight constant hydrocortisone or normal saline (control) infusion.405
Infusions were given in a randomized, double-blind order and continued during and after β-406
adrenoceptor stimulation with isoprenaline (A). Mean changes in supraclavicular region (TSCR, grey407
circles) and non-adipose tissue reference (TREF, open squares) temperatures (dotted line indicates time408
of meal) (B), individual responses (fasting, open squares; postprandial, black squares) (C), and changes409
in core temperature (fasting, open circles; postprandial, black squares) (D) following the meal. *p<0.05410
compared to fasting baseline, n=8411
412
Figure 2413
Metabolic and cardiovascular responses following saline infusion (S) or hydrocortisone infusion (HC)414
at baseline and during an isoprenaline infusion (ISO, dotted lines indicate infusion period). Plasma415
cortisol concentrations (saline, open circles; hydrocortisone, black squares) (A), non-esterified fatty416
acids (NEFA) (saline, open circles; hydrocortisone, black squares) (B), glucose (saline, open circles;417
hydrocortisone, black squares) (C), supraclavicular temperature (TSCR) (saline, open circles;418
hydrocortisone, black circles) (D) and core temperature at baseline (saline, open squares;419
hydrocortisone, black squares) (E). Systolic (sys) and diastolic (dia) blood pressure (BP) and heart rate420
(HR) at baseline (saline, open bars; hydrocortisone, black bars) (F). *p<0.05 vs. control, n=8421
422
Figure 3423
BAT thermogenic responses. Supraclavicular temperature (TSCR) and non-adipose tissue reference point424
(TREF) following saline (S) infusion (TSCR, grey circles; TREF open squares) (A) or hydrocortisone (HC)425
infusion (TSCR, grey circles; TREF open squares) (B) during and after isoprenaline stimulation (ISO,426
dotted lines indicate infusion period). Individual peak BAT temperatures during ISO (S, open circles;427
HC, black circles) (C). Change in temperature during ISO or following a standardized meal (TSCR, grey428
bars; TREF open bars) (D). *p<0.001 vs. basal, †p<0.05 vs. saline, #p<0.001 vs. saline, ##p<0.001 vs.429
TREF, n=8430
431
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Table 1: Baseline anthropometric and metabolic characteristics of participants, n=8440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
Median and range shown. BMI, body mass index; WHR, waist-to-hip ratio; BP, blood pressure; TSH,460
thyroid stimulating hormone; FT4, free thyroxine461
462
463
464
Characteristic
Age (years) 20 (18-34)
Weight (kg) 75.0 (61.5-81.7)
BMI (kg/m2) 23.0 (20.6-24.2)
WHR 0.84 (0.78-0.9)
Trunk fat (kg) 7.7 (5.1-9.2)
Leg fat (kg) 5.5 (4.3-7.5)
Visceral fat (kg) 0.2 (0.1-0.4)
Systolic BP (mmHg) 124 (105-145)
Diastolic BP (mmHg) 72 (59-79)
Heart rate (bpm) 58 (53-62)
Fasting glucose (mg/dL) 113 (89-122)
Fasting insulin (pmol/L) 30.6 (14.4-68.5)
Fasting NEFA (µmol/L) 707 (450-873)
TSH (mIU/L) 1.30 (0.93-4.83)
FT4 (pmol/L) 17.7 (15.0-18.8)
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Table 2: Comparison of insulin and C-peptide AUC, and homeostatic model assessment (HOMA)465
indexes during basal and isoprenaline-stimulated conditions, n=8466
Control Cortisol
P value
control vs
cortisol
P value
basal vs
isoprenaline
Basal ISO Basal ISO Basal ISO Control Cortisol
Insulin
(pmol/L) 30.4±6.0 100.4±15.7 55.2±7.4 206.7±30.5 0.025 0.012 0.012 0.012
C-peptide
(pmol/mL) 0.25±0.03 0.47±0.05 0.38±0.04 0.90±0.09 0.001 0.001 <0.0001 <0.0001
Control Cortisol P value
Δ insulin basal to ISO (pmol/L) 70.0±10.1 151.5±28.9 0.012 
Δ C-peptide basal to ISO (pmol/mL) 0.22±0.03 0.52±0.07 0.012 
HOMA %B 42.2±5.9 40.5±4.5 0.731
HOMA %S 192.2±29.5 105.9±19.2 0.004
HOMA IR 0.62±0.11 1.11±0.16 0.016
Mean and SEM shown467
468
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Supplemental data469
Supplemental Table 1: Environmental temperatures in relation to the time of year throughout which470
each study was conducted. Environmental outside temperature data obtained from the Meteorological471
office. Note overnight duration of infusion as outlined in main text.472
473
Saline infusion
Participant Date of study Environmental roomtemperature (°C)
Environmental outside
temperature (°C)
Infusion
start
Infusion
end
Infusion
start
Infusion
end
1 13/01/2015 23.7 25.2 6 4
2 24/02/2015 22.8 25.8 6 5
3 11/02/2015 24.4 24.0 5 5
4 21/01/2015 24.2 24.6 4 4
5 22/01/2015 24.1 23.9 4 4
6 26/02/2015 24.2 23.2 5 5
7 26/03/2015 25.2 25.2 7 7
8 24/03/2015 24.1 24.6 7 7
Mean ±
SEM 24.1 ± 0.2 24.6 ± 0.3 5.5 ± 0.4 5.1 ± 0.4
474
Hydrocortisone infusion
Participant Date of study Environmental roomtemperature (°C)
Environmental outside
temperature (°C)
Infusion
start
Infusion
end
Infusion
start
Infusion
end
1 10/02/2015 23.7 23.9 4 5
2 14/01/2015 24.0 25.3 4 5
3 15/01/2015 22.2 23.5 5 4
4 25/02/2015 25.5 26.2 5 5
5 12/02/2015 24.0 24.8 5 4
6 25/03/2015 25.2 23.6 7 7
7 11/03/2015 25.1 25.2 6 6
8 12/03/2015 25.3 23.6 6 5
Mean ±
SEM 24.4 ± 0.4 24.5 ± 0.4 5.3 ± 0.4 5.1 ± 1.0
475
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476
Supplemental Figure 1477
Systolic (sys) and diastolic (dia) blood pressure before (basal) and after 50 min of isoprenaline478
infusion (ISO), under control conditions (open bars) and following an overnight hydrocortisone479
infusion (black bars). * p<0.05 compared to basal control, # p=<0.05 compared to basal480
hydrocortisone, n=8481
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482
Supplemental Figure 2483
Individual BAT temperature responses from baseline (open circles) to peak (black circles) following484
saline infusion (A) or hydrocortisone infusion (B), n=8485
486
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487
Supplemental Figure 3488
Brown (BAT) and white adipose tissue (WAT) thermogenic responses to isoprenaline (ISO) using skin489
contact temperature sensors placed over the supraclavicular BAT region (grey circles and bars) or over490
an area of abdominal WAT (open squares and bars) under control conditions (A) and following an491
overnight hydrocortisone infusion (B). Dotted line indicates start of ISO infusion. Mean temperatures492
at baseline and at peak during ISO (C, control and D, hydrocortisone). * p<0.05 peak/post-ISO BAT493
temperaure compared to basal BAT, # p<0.05 peak/post-ISO WAT temperature compared to basal494
WAT, ## p<0.05 compared to basal BAT, n=8495
496
497
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498
Supplemental Figure 4499
Whole body energy expenditure under control conditions (open bars) and following an overnight500
hydrocortisone infusion (black bars) during basal conditions and after 50 min of isoprenaline infusion501
(peak). * p<0.05 compared to basal control, # p=<0.05 compared to basal hydrocortisone, n=8502
503
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512
Supplemental Figure 5513
Individual peak core temperature responses to isoprenaline infusion following saline infusion (S, open514
circles) or hydrocortisone infusion (HC, black squares), n=8515
516
